Status:

RECRUITING

A Registry-Based Cohort Study on the Clinical Outcomes of Spinal Cord Glioma Resection Via the Dorsolateral Sulcus Approach

Lead Sponsor:

Beijing Tiantan Hospital

Conditions:

Spinal Cord Cancer

Spinal Cord Neoplasm

Eligibility:

All Genders

3-75 years

Brief Summary

Spinal cord gliomas are the most common type of primary intramedullary malignant tumors, with a low incidence and a peak onset age of approximately 35 years. They are slightly more prevalent in males ...

Detailed Description

Spinal cord gliomas are rare primary intramedullary tumors characterized by lateralized infiltrative growth and limited treatment options beyond surgical resection. Due to the anatomical complexity an...

Eligibility Criteria

Inclusion Criteria:

  1. Age between 3 and 75 years
  2. Undergoing surgical resection of spinal cord tumor
  3. Histopathological diagnosis of spinal cord glioma based on routine pathological examination
  4. Availability of complete clinical data and willingness to participate in follow-up
  5. Informed consent obtained from the patient and/or legal guardians or immediate family members

Exclusion Criteria:

  1. Age under 3 years or over 75 years
  2. Receipt of radiotherapy, chemotherapy, or anti-tumor biological therapy within 1 month prior to enrollment
  3. Receipt of immunotherapy within 3 months prior to enrollment
  4. Participation in other clinical trials within 3 months prior to enrollment
  5. History of severe allergic reactions or known allergy-prone constitution
  6. Pregnant or breastfeeding women, or individuals of childbearing potential not using adequate contraception
  7. Presence of other severe medical conditions or uncontrolled infections
  8. History of drug abuse, substance misuse, chronic alcoholism, or HIV infection
  9. Uncontrolled epileptic seizures or psychiatric disorders resulting in loss of self-control

Key Trial Info

Start Date :

January 1 2022

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 31 2026

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT07066475

Start Date

January 1 2022

End Date

December 31 2026

Last Update

July 23 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Beijing Neurosurgical Institute, Beijing Tiantan Hospital, Capital Medical University

Beijing, Beijing Municipality, China, 100070

A Registry-Based Cohort Study on the Clinical Outcomes of Spinal Cord Glioma Resection Via the Dorsolateral Sulcus Approach | DecenTrialz